Literature DB >> 18468812

Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy.

Hale B Caglar1, Roy B Tishler, Megan Othus, Elaine Burke, Yi Li, Laura Goguen, Lori J Wirth, Robert I Haddad, Carl M Norris, Laurence E Court, Donald J Aninno, Marshall R Posner, Aaron M Allen.   

Abstract

PURPOSE: To evaluate early swallowing after intensity-modulated radiotherapy for head and neck squamous cell carcinoma and determine factors correlating with aspiration and/or stricture. METHODS AND MATERIALS: Consecutive patients treated with intensity-modulated radiotherapy with or without chemotherapy between September 2004 and August 2006 at the Dana Farber Cancer Institute/Brigham and Women's Hospital were evaluated with institutional review board approval. Patients underwent swallowing evaluation after completion of therapy; including video swallow studies. The clinical- and treatment-related variables were examined for correlation with aspiration or strictures, as well as doses to the larynx, pharyngeal constrictor muscles, and cervical esophagus. The correlation was assessed with logistic regression analysis.
RESULTS: A total of 96 patients were evaluated. Their median age was 55 years, and 79 (82%) were men. The primary site of cancer was the oropharynx in 43, hypopharynx/larynx in 17, oral cavity in 13, nasopharynx in 11, maxillary sinus in 2, and unknown primary in 10. Of the 96 patients, 85% underwent definitive RT and 15% postoperative RT. Also, 28 patients underwent induction chemotherapy followed by concurrent chemotherapy, 59 received concurrent chemotherapy, and 9 patients underwent RT alone. The median follow-up was 10 months. Of the 96 patients, 31 (32%) had clinically significant aspiration and 36 (37%) developed a stricture. The radiation dose-volume metrics, including the volume of the larynx receiving >or=50 Gy (p = 0.04 and p = 0.03, respectively) and volume of the inferior constrictor receiving >or=50 Gy (p = 0.05 and p = 0.02, respectively) were significantly associated with both aspiration and stricture. The mean larynx dose correlated with aspiration (p = 0.003). Smoking history was the only clinical factor to correlate with stricture (p = 0.05) but not aspiration.
CONCLUSION: Aspiration and stricture are common side effects after intensity-modulated radiotherapy for head-and-neck squamous cell carcinoma. The dose given to the larynx and inferior constrictors correlated with these side effects.

Entities:  

Mesh:

Year:  2008        PMID: 18468812     DOI: 10.1016/j.ijrobp.2008.02.048

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  66 in total

1.  Intensity-modulated radiotherapy for laryngeal and hypopharyngeal cancer: minimization of late dysphagia without jeopardizing tumor control.

Authors:  Anouchka Modesto; Anne Laprie; Laure Vieillevigne; Pierre Graff; Jérôme Sarini; Sébastien Vergez; Jean-Pierre Delord; Jean-Claude Farenc; Emmanuelle Vigarios; Thomas Filleron; Michel Rives
Journal:  Strahlenther Onkol       Date:  2014-11-01       Impact factor: 3.621

Review 2.  Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers.

Authors:  Katherine A Hutcheson; Jan S Lewin
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

3.  Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.

Authors:  David L Schwartz; Katherine Hutcheson; Denise Barringer; Susan L Tucker; Merrill Kies; F Christopher Holsinger; K Kian Ang; William H Morrison; David I Rosenthal; Adam S Garden; Lei Dong; Jan S Lewin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

4.  Swallowing function following postchemoradiotherapy neck dissection: review of findings and analysis of contributing factors.

Authors:  Claudia I Chapuy; Donald J Annino; Anna Snavely; Yi Li; Roy B Tishler; Charles M Norris; Robert I Haddad; Laura A Goguen
Journal:  Otolaryngol Head Neck Surg       Date:  2011-09       Impact factor: 3.497

5.  The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy.

Authors:  Beste M Atasoy; Oya Yonal; Birsen Demirel; Faysal Dane; Yusuf Yilmaz; Cem Kalayci; Ufuk Abacioglu; Nese Imeryuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-04-07       Impact factor: 2.503

Review 6.  Organ-sparing radiation therapy for head and neck cancer.

Authors:  XiaoShen Wang; ChaoSu Hu; Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2011-07-26       Impact factor: 66.675

Review 7.  Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: is it an underestimated phenomenon? A radiation oncologist's perspective.

Authors:  J Cacicedo; A Dal Pra; F Alongi; A Navarro
Journal:  Eur J Clin Nutr       Date:  2015-04-29       Impact factor: 4.016

Review 8.  A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy : A systematic review by the Italian Head and Neck Radiotherapy Study Group.

Authors:  Stefano Ursino; Elisa D'Angelo; Rosario Mazzola; Anna Merlotti; Riccardo Morganti; Agostino Cristaudo; Fabiola Paiar; Daniela Musio; Daniela Alterio; Almalina Bacigalupo; Elvio Grazioso Russi; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2017-06-14       Impact factor: 3.621

9.  Delineating brachial plexus, cochlea, pharyngeal constrictor muscles and optic chiasm in head and neck radiotherapy: a CT-based model atlas.

Authors:  Domenico Genovesi; Francesca Perrotti; Marianna Trignani; Angelo Di Pilla; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Massimo Caulo; Massimo Savastano; Armando Tartaro; Antonio Raffaele Cotroneo; Giampiero Ausili Cèfaro
Journal:  Radiol Med       Date:  2014-08-05       Impact factor: 3.469

10.  Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.

Authors:  Baoqing Li; Dan Li; Derick H Lau; D Gregory Farwell; Quang Luu; David M Rocke; Kathleen Newman; Jean Courquin; James A Purdy; Allen M Chen
Journal:  Radiat Oncol       Date:  2009-11-12       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.